DK0398619T3 - Stabiliserede præparater indeholdende epidermal vækstfaktor - Google Patents

Stabiliserede præparater indeholdende epidermal vækstfaktor

Info

Publication number
DK0398619T3
DK0398619T3 DK90305185.2T DK90305185T DK0398619T3 DK 0398619 T3 DK0398619 T3 DK 0398619T3 DK 90305185 T DK90305185 T DK 90305185T DK 0398619 T3 DK0398619 T3 DK 0398619T3
Authority
DK
Denmark
Prior art keywords
growth factor
epidermal growth
preparations containing
containing epidermal
stabilized preparations
Prior art date
Application number
DK90305185.2T
Other languages
Danish (da)
English (en)
Inventor
Amy L Finkenaur
John K Cini
Original Assignee
Ethicon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethicon Inc filed Critical Ethicon Inc
Application granted granted Critical
Publication of DK0398619T3 publication Critical patent/DK0398619T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/315—Zinc compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
DK90305185.2T 1989-05-16 1990-05-15 Stabiliserede præparater indeholdende epidermal vækstfaktor DK0398619T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/353,131 US5130298A (en) 1989-05-16 1989-05-16 Stabilized compositions containing epidermal growth factor

Publications (1)

Publication Number Publication Date
DK0398619T3 true DK0398619T3 (da) 1993-10-04

Family

ID=23387889

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90305185.2T DK0398619T3 (da) 1989-05-16 1990-05-15 Stabiliserede præparater indeholdende epidermal vækstfaktor

Country Status (11)

Country Link
US (1) US5130298A (pt)
EP (1) EP0398619B1 (pt)
JP (1) JP2763815B2 (pt)
KR (1) KR900017580A (pt)
AU (1) AU630952B2 (pt)
CA (1) CA2016659C (pt)
DE (1) DE69002795T2 (pt)
DK (1) DK0398619T3 (pt)
ES (1) ES2058799T3 (pt)
GR (1) GR1000392B (pt)
PT (1) PT94037B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326154B1 (en) * 1990-11-19 2001-12-04 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
AU2489992A (en) * 1991-08-16 1993-03-16 Chiron Corporation Muteins of epidermal growth factor exhibiting enhanced binding at low ph
US5618544A (en) * 1992-08-12 1997-04-08 Bays-Brown Dermatologics, Inc. Method of decreasing cutaneous senescence
US5759548A (en) * 1993-11-30 1998-06-02 Lxr Biotechnology Inc. Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
AU1847695A (en) * 1994-02-22 1995-09-04 Syntex-Synergen Neuroscience Joint Venture, The Pharmaceutical formulations of cntf
US6048545A (en) * 1994-06-24 2000-04-11 Biozone Laboratories, Inc. Liposomal delivery by iontophoresis
CN1043732C (zh) * 1994-12-22 1999-06-23 大连医科大学 治疗口腔糜烂面的新型药膜
AU7678196A (en) * 1995-11-13 1997-06-05 Minimed, Inc. Methods and compositions for the delivery of monomeric proteins
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
KR100533531B1 (ko) 1996-11-06 2005-12-06 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 분리된 종양괴사인자 수용체 방출효소, 그 효소로 이루어지는 조성물 및 그것의 사용방법
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US6949528B1 (en) * 1998-03-18 2005-09-27 Goddard John G Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
US7033615B2 (en) * 1999-07-09 2006-04-25 Cancer2 Inc. Methods for regulating levels of zinc, cadmium and calcium in humans and for diagnosing, or screening for the risk of developing, diseases associated with abnormal levels of cadmium, zinc and calcium in body fluids and tissues
US6541447B1 (en) 1999-09-01 2003-04-01 B & M Healthcare Technologies, Inc. Wound healing composition and method for use thereof
GB0001621D0 (en) 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
US20060063738A1 (en) * 2000-02-28 2006-03-23 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
US20070087965A1 (en) * 2005-10-03 2007-04-19 Neirinckx Rudi D Treatment of psoriasis through down-regulation of the egf-receptor with topically applied egf
US7015199B1 (en) * 2000-06-02 2006-03-21 Neirinckx Rudi D Treatment of psoriasis through down-regulation of the EGF-receptor with topically-applied EGF
AU7907301A (en) 2000-07-28 2002-02-13 Christopher J Murphy Transplant media
HK1077740A1 (en) * 2001-12-20 2006-02-24 Ct Ingenieria Genetica Biotech Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation
WO2003075949A1 (en) * 2002-03-12 2003-09-18 Bio-Click Technologies Ltd. Method and composition for treating skin wounds with epidermal growth factor
SE0202719D0 (sv) * 2002-09-13 2002-09-13 Pharmacia Ab Process for mfg crystals of growth hormone
US20050214382A1 (en) * 2004-03-29 2005-09-29 Erning Xia Zinc preservative composition and method of use
US20070207209A1 (en) * 2004-08-27 2007-09-06 Murphy Christopher J Trophic factor combinations for nervous system treatment
CN101217938A (zh) 2005-05-27 2008-07-09 博哈拉特生物技术国际有限公司 表皮生长因子组合物，其方法及其应用
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
CU23388B6 (es) * 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
CN101522171A (zh) * 2006-09-28 2009-09-02 爱尔康研究有限公司 自身防腐的水性药物组合物
CU23526B6 (es) * 2006-10-03 2010-05-19 Ct Ingenieria Genetica Biotech Método para la restauración morfofuncional de nervios periféricos en la neuropatía diabética
KR100784134B1 (ko) * 2006-10-09 2007-12-12 주식회사 대웅 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물
DK2254549T4 (da) * 2008-03-17 2019-07-22 Alcon Res Ltd Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser
JP5303322B2 (ja) * 2009-03-13 2013-10-02 ピアス株式会社 皮膚外用組成物
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
CN102811704A (zh) * 2010-01-06 2012-12-05 奥夫莱夫塔埃克尼公司 稳定化的植物来源的生长因子在皮肤护理中的使用方法
ES2919136T3 (es) 2010-08-11 2022-07-22 Ironwood Pharmaceuticals Inc Formulaciones estables de linaclotida
JP5798356B2 (ja) * 2011-04-06 2015-10-21 一般財団法人化学及血清療法研究所 新規インフルエンザワクチン安定化剤
ES2676023T3 (es) 2013-03-15 2018-07-16 F. Hoffmann-La Roche Ag Polipéptidos de IL-22 y proteínas de fusión de IL-22 Fc y métodos de uso
US9283172B2 (en) 2013-12-13 2016-03-15 Growgene Biotech Inc. Use of stem cell conditioned medium to induce ZO-1 proteins expression for skin regeneration, repair and firming
KR101868966B1 (ko) * 2016-05-12 2018-06-19 주식회사 엔씨엘바이오 열 안정성을 증진시킨 사람 상피세포 성장인자의 조성물
CR20200327A (es) 2018-01-26 2020-11-05 Genentech Inc Proteínas de fusión fc il-22 y métodos de uso
PL3743088T3 (pl) 2018-01-26 2023-03-20 F. Hoffmann-La Roche Ag Kompozycje i sposoby stosowania il-22 fc
WO2019165140A1 (en) 2018-02-21 2019-08-29 Genentech, Inc. DOSING FOR TREATMENT WITH IL-22 Fc FUSION PROTEINS

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA972288A (en) * 1971-01-20 1975-08-05 Gyorgy Hajos Process for the preparation of new complexes of biologically active peptides, polypeptides, proteins or derivatives or salts thereof having prolonged and/or increased activity
US3887704A (en) * 1974-03-12 1975-06-03 Joseph Lichtenstein Aqueous zinc solutions for physiological use
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
DK113585D0 (da) * 1985-03-12 1985-03-12 Novo Industri As Nye peptider
HU194280B (en) * 1985-10-22 1988-01-28 Richter Gedeon Vegyeszet Process for producing new gonadoliberin analogues of high effectivity and pharmaceutical compositions containing them
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
AU8175387A (en) * 1986-10-20 1988-05-06 Novo Industri A/S Protamine zinc insulin preparations
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US4764592A (en) * 1987-04-23 1988-08-16 Eli Lilly And Company Crystalline human proinsulin and process for its production
DE3731255A1 (de) * 1987-09-17 1989-04-06 Boehringer Ingelheim Int Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen
US5272063A (en) * 1988-11-22 1993-12-21 Syntex (U.S.A.) Inc. Process of making human nerve growth factor

Also Published As

Publication number Publication date
PT94037A (pt) 1991-01-08
EP0398619B1 (en) 1993-08-18
CA2016659A1 (en) 1990-11-16
AU5496890A (en) 1990-11-22
DE69002795D1 (de) 1993-09-23
GR1000392B (el) 1992-06-30
JPH0334992A (ja) 1991-02-14
CA2016659C (en) 1996-12-10
AU630952B2 (en) 1992-11-12
DE69002795T2 (de) 1994-01-13
EP0398619A3 (en) 1991-04-03
GR900100334A (en) 1991-10-10
KR900017580A (ko) 1990-12-19
EP0398619A2 (en) 1990-11-22
JP2763815B2 (ja) 1998-06-11
PT94037B (pt) 1996-11-29
ES2058799T3 (es) 1994-11-01
US5130298A (en) 1992-07-14

Similar Documents

Publication Publication Date Title
DK0398619T3 (da) Stabiliserede præparater indeholdende epidermal vækstfaktor
DK579787A (da) Stabiliserede praeparater indeholdende epidermal vaekstfaktor
DK516788D0 (da) Stabile lyophiliserede praeparater indeholdende vaekstfaktorer
ATA165489A (de) Nitroglycerinhaltige spray-präparate
ZA878283B (en) Stabilized compositions containing epidermal growth factor
NO904584L (no) Preparater inneholdende hyaluronsyreforbindelser samt fremgangsmaate for fremstilling derav.
DK333487D0 (da) Calciumholdige farnaceutiske praeparater
NO914160D0 (no) Stabilisert vismutoksid
DK565089D0 (da) Hudpraeparater
NO921929L (no) Stabiliserte stannofluoridpreparater for munnpleie
ATA41090A (de) Verbesserte puzzolanische zubereitungen
NO169173C (no) Veksthormon-frigjoerende peptider
DE69016867D1 (de) Acylierter Epidermis-Wachstumsfaktor.
DK84489A (da) Praeparater
KR890700660A (ko) 표피 생장 인자-결실 프라스미노겐 활성화제
DK465487D0 (da) Anxiolytiske praeparater indeholdende dioxopiperidinderivater
IT1227462B (it) Procedimento di preparazione di 6-ossopenicillanati
DE69028206D1 (de) Stabilisierte polyacetalzubereitungen
DK503386D0 (da) Peptidpraeparater
DK472189D0 (da) Vaeksthormon
DK376089D0 (da) Vaekstoegende praeparater
GB8618801D0 (en) Biological preparations
DK75390A (da) Filmdannende praeparater
KR860009201U (ko) 육모용 폿트
GB8914671D0 (en) Hair growth compound